Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Epistaxis
ADR ID BADD_A01528
ADR Hierarchy
22      Respiratory, thoracic and mediastinal disorders
22.04      Upper respiratory tract disorders (excl infections)
22.04.03      Nasal disorders NEC
22.04.03.001      Epistaxis
24      Vascular disorders
24.07      Vascular haemorrhagic disorders
24.07.01      Haemorrhages NEC
24.07.01.005      Epistaxis
Description A disorder characterized by bleeding from the nose. [CTCAE] Bleeding from the nose. [MeSH]
MedDRA Code 10015090
MeSH ID D004844
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Bleeding nose | Epistaxis | Haemorrhage nasal | Hemorrhage nasal | Nasal bleeding | Nasal mucus blood tinged | Nose bleed | Nose bleeds | Nosebleed | Chronic epistaxis | Blood clot in nose | Nasal Bleeding | Bleeding, Nasal | Bleedings, Nasal | Nasal Bleedings | Nose Bleed | Nose Bleeds | Nosebleeds
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00921Flunisolide hemihydrate--
BADD_D00931Fluorouracil--
BADD_D00932Fluoxetine--
BADD_D00933Fluoxetine hydrochloride--
BADD_D00941Flurbiprofen--
BADD_D00945Fluticasone--
BADD_D00946Fluticasone furoate0.002384%
BADD_D00947Fluticasone propionate0.005437%
BADD_D00950Fluvoxamine--
BADD_D00951Fluvoxamine maleate--
BADD_D00957Fondaparinux sodium--
BADD_D00967Fosinopril--
BADD_D00968Fosinopril sodium--
BADD_D00969Fosinoprilat--
BADD_D00970Fosphenytoin--
BADD_D00971Fosphenytoin sodium--
BADD_D00974Fragmin--
BADD_D00976Frovatriptan--
BADD_D00977Frovatriptan succinate--
BADD_D00979Furosemide0.000167%
BADD_D00981Gabapentin--
BADD_D00989Gadolinium--
BADD_D00994Gadoversetamide--
BADD_D00996Galantamine--
BADD_D00997Galantamine hydrobromide--
BADD_D01006Gatifloxacin--
BADD_D01008Gefitinib0.000604%
BADD_D01015Gemtuzumab ozogamicin--
BADD_D01020Glatiramer--
BADD_D01021Glatiramer acetate--
The 8th Page    First    Pre   8 9 10 11 12    Next   Last    Total 20 Pages